MxA interacts with and is modified by the SUMOylation machinery

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Mx proteins are large GTPases crucial for innate immunity against viral infections, triggered by interferons.
• Human MxA protein exhibits broad antiviral activity and possesses self-assembly properties.
• The role of post-translational modifications, such as SUMOylation, in MxA function is largely unexplored.

Purpose of the Study:

• To identify MxA binding partners involved in its antiviral mechanism.
• To investigate the interaction between MxA and the SUMOylation pathway components.
• To determine the functional significance of MxA SUMOylation in its antiviral activity.

Main Methods:

• Yeast two-hybrid screening to identify MxA interacting proteins.
• Co-immunoprecipitation and confocal microscopy to confirm protein interactions and localization.
• Site-directed mutagenesis to investigate the role of SUMOylation sites and SUMO-interacting motifs (SIMs).
• Viral replication assays to assess the antiviral activity of MxA mutants.

Main Results:

• Identified 27 MxA binding partners, including SUMOylation machinery components like SUMO1 and Ubc9.
• Confirmed MxA interaction with SUMO1 and Ubc9, and mapped their binding domains.
• Identified a SUMO conjugation site (K48) and two putative SIMs in MxA.
• Mutations in SIMs reduced MxA antiviral activity, but SUMOylation-deficient MxA (MxAK48R) retained antiviral function.
• MxA SUMOylation was not essential for its ability to oligomerize or inhibit VSV and Influenza A virus replication.

Conclusions:

• MxA interacts with the SUMOylation machinery, suggesting a regulatory role for SUMOylation.
• While SUMOylation sites and SIMs are identified, MxA SUMOylation is not critical for its core antiviral functions.
• Further research is needed to elucidate the precise role of MxA SUMOylation in viral resistance.